Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Community Hypertension Assessment Trial (CHAT)
This study has been completed.
Sponsors and Collaborators: Hamilton Health Sciences
University of Ottawa
Information provided by: McMaster University
ClinicalTrials.gov Identifier: NCT00217334
  Purpose

The Community Hypertension Assessment Trial (CHAT) is an investigation of the effect of community pharmacy based blood pressure (BP) monitoring sessions led by peer health educators, with feedback to family physicians, on the monitoring and management of blood pressure among older adults.


Condition Intervention
Hypertension
Behavioral: Volunteer-led pharmacy sessions with feedback to physicians

MedlinePlus related topics: High Blood Pressure
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Parallel Assignment
Official Title: A Pragmatic Trial of Community Pharmacy Blood Pressure Clinics Linked With Family Medicine Practices to Improve the Monitoring and Management of High Blood Pressure Among Older Adults

Further study details as provided by McMaster University:

Primary Outcome Measures:
  • Difference in the change from baseline to 12 months exit
  • Assessment in the mean percent of patients with adequate
  • Assessment / blood pressure (BP) control in intervention compared to control practices

Secondary Outcome Measures:
  • Percent of patients with mean BP 140-159 / 90-99
  • Percent of patients with mean BP 160-179 / 100-110
  • Percent of patients with mean BP >180 / >110

Estimated Enrollment: 28
Study Start Date: November 2002
Estimated Study Completion Date: January 2005
Detailed Description:

Hypertension affects about 22% of Canadian adults and is a modifiable risk factor for cardiovascular disease. Most countries have increasing older adult populations and hypertension prevalence increases with age. However, the “rule of halves” still applies in many primary health care settings: half of the hypertensive patients are undiagnosed, half of the diagnosed patients are untreated, and half of the treated patients are uncontrolled.

Family physicians were randomly selected and approached to participate in CHAT. Paired cluster randomization was used, with practices as the unit of randomization. Data on blood pressure (BP) readings in the last year, diagnosis of hypertension, diagnosis of diabetes and/or target organ damage, and a current antihypertensive profile was extracted from the health records of 55 patients randomly selected in each practice. In practices allocated to the Intervention group, physicians sent a letter, with assistance from research staff, to invite all of their eligible patients 65 years and older to attend one or two BP sessions in nearby pharmacies. Inclusion criteria required that patients be regular patients in the practice, community-dwelling, and mobile/well enough to attend community sessions.

Public health authorities trained older adult volunteer peer health educators to assist patients at the sessions to accurately measure their BP using a validated automated device, and record BP readings and cardiovascular risk factors. The volunteers provided education about hypertension but did not perform a clinical function. A recommendation protocol ensured that the pharmacist and, if necessary, the physician was notified if patients had a very high BP or a very low BP accompanied by symptoms. A public health nurse was ‘on-call’ during the sessions in case clinical advice was needed. A volunteer coordinator facilitated the transfer of readings and patient-reported cardiovascular risk factors to physicians.

Accurate BP readings were obtained from the BPM-100 automated BP measuring device. Questionnaires were used to obtain self-report data on cardiovascular disease risk factors from patients, knowledge and attitudes about BP control from physicians, and attitudes and satisfaction with the program from peer health educators, pharmacists, and public health nurses.

The primary outcome measure followed an 'intention to treat' approach. The primary endpoint was the difference in the change from 12 months pre- to 12 months post-intervention in the proportion of eligible patients with a BP reading recorded in their health record with mean systolic <=140 mm Hg or mean diastolic <=90 mmHg; <=130 or <=80 if target organ damage or diabetes is present.

This trial is a collaboration by the Department of Family Medicine, McMaster University and the Elisabeth Bruyère Research Institute, a University of Ottawa and SCO Service Partnership.

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

28 family physicians were recruited; all eligible patients in practices allocated to the intervention arm were invited to the program. A randomly selected set of 50 charts per practice were audited, regardless of session attendance.

Physician Practices

Inclusion Criteria:

  • Non-academic (none of its members are full-time faculty members)
  • Full-time
  • Regular family practice in terms of size and case-mix
  • Able to provide an electronic roster that includes a mailing address of their patients 65 years and older

Exclusion Criteria:

  • work in walk-in clinics or emergency departments
  • about to retire
  • work part-time
  • fewer than 50 patients 65 years or older
  • specialized practice profile

Patients

Inclusion Criteria:

  • Community-dwelling
  • 65 years or older
  • Visited the practice at least once in the last year
  • Considered regular patients by the physician

Exclusion Criteria:

  • Terminally ill
  • Scheduled to have surgery during the program period
  • Not mobile to visit the pharmacy
  • Non-English-speaking and unable to attend with an English-speaking companion
  • Significant cognitive impairment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00217334

Locations
Canada, Ontario
McMaster University
Hamilton, Ontario, Canada, L8N 3Z5
Sponsors and Collaborators
Hamilton Health Sciences
University of Ottawa
Investigators
Principal Investigator: Janusz A Kaczorowski, PhD McMaster University
Principal Investigator: Larry W Chambers, PhD Elisabeth Bruyere Research Institute
  More Information

program website with link to trial  This link exits the ClinicalTrials.gov site

Publications of Results:
Other Publications:
Study ID Numbers: 0517-149-02, CIHR MOP 57902, McMaster CSD 2001HO4527
Study First Received: September 19, 2005
Last Updated: September 19, 2005
ClinicalTrials.gov Identifier: NCT00217334  
Health Authority: Canada: Health Canada

Keywords provided by McMaster University:
Hypertension
Cardiovascular diseases
Randomized controlled trial
Cluster randomization
Primary care

Study placed in the following topic categories:
Vascular Diseases
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009